Co-Authors
This is a "connection" page, showing publications co-authored by Peter Inglesby and Ben Goldacre.
Connection Strength
1.736
-
Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet Reg Health Eur. 2021 Jul; 6:100109.
Score: 0.236
-
Identifying Care Home Residents in Electronic Health Records - An OpenSAFELY Short Data Report. Wellcome Open Res. 2021; 6:90.
Score: 0.236
-
Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? - Authors' reply. Lancet Rheumatol. 2021 Mar; 3(3):e172-e173.
Score: 0.232
-
HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform. Lancet HIV. 2021 01; 8(1):e24-e32.
Score: 0.229
-
Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform. Lancet Rheumatol. 2021 Jan; 3(1):e19-e27.
Score: 0.228
-
Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020 08; 584(7821):430-436.
Score: 0.223
-
Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br J Gen Pract. 2021 11; 71(712):e806-e814.
Score: 0.061
-
Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform. BMJ. 2021 07 14; 374:n1592.
Score: 0.060
-
Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet. 2021 05 08; 397(10286):1711-1724.
Score: 0.059
-
Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England. BMJ. 2021 03 18; 372:n628.
Score: 0.058
-
Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts. Ann Rheum Dis. 2021 07; 80(7):943-951.
Score: 0.058
-
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med. 2020 11; 8(11):1106-1120.
Score: 0.057